State of Alaska Department of Revenue’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-20,687
| Closed | -$2.03M | – | 2082 |
|
|
2025
Q2 | $2.03M | Sell |
20,687
-155
| -0.7% | -$14.7K | 0.02% | 703 |
|
|
2025
Q1 | $1.93M | Buy |
20,842
+105
| +0.5% | +$9.68K | 0.02% | 688 |
|
|
2024
Q4 | $1.88M | Buy |
20,737
+16,955
| +448% | +$1.56M | 0.02% | 729 |
|
|
2024
Q3 | $365K | Buy |
3,782
+255
| +7% | +$24.9K | ﹤0.01% | 1504 |
|
|
2024
Q2 | $323K | Hold |
3,527
| – | – | ﹤0.01% | 1507 |
|
|
2024
Q1 | $325K | Hold |
3,527
| – | – | ﹤0.01% | 1515 |
|
|
2023
Q4 | $335K | Sell |
3,527
-390
| -10% | -$36.4K | ﹤0.01% | 1515 |
|
|
2023
Q3 | $365K | Sell |
3,917
-125
| -3% | -$11.6K | ﹤0.01% | 1463 |
|
|
2023
Q2 | $369K | Sell |
4,042
-437
| -10% | -$35.9K | ﹤0.01% | 1488 |
|
|
2023
Q1 | $329K | Sell |
4,479
-25
| -0.6% | -$2.16K | ﹤0.01% | 1516 |
|
|
2022
Q4 | $376K | Hold |
4,504
| – | – | ﹤0.01% | 1468 |
|
|
2022
Q3 | $435K | Sell |
4,504
-175
| -4% | -$20.9K | 0.01% | 1366 |
|
|
2022
Q2 | $491K | Buy |
4,679
+90
| +2% | +$11.5K | 0.01% | 1360 |
|
|
2022
Q1 | $790K | Sell |
4,589
-130
| -3% | -$19.4K | 0.01% | 1161 |
|
|
2021
Q4 | $763K | Sell |
4,719
-290
| -6% | -$46.6K | 0.01% | 1236 |
|
|
2021
Q3 | $746K | Sell |
5,009
-49
| -1% | -$10.2K | 0.01% | 1260 |
|
|
2021
Q2 | $1.24M | Sell |
5,058
-89
| -2% | -$23.4K | 0.01% | 958 |
|
|
2021
Q1 | $1.36M | Sell |
5,147
-184
| -3% | -$51.9K | 0.01% | 876 |
|
|
2020
Q4 | $1.56M | Sell |
5,331
-208
| -4% | -$53.3K | 0.02% | 735 |
|
|
2020
Q3 | $1.31M | Sell |
5,539
-224
| -4% | -$50.9K | 0.02% | 738 |
|
|
2020
Q2 | $1.14M | Buy |
5,763
+205
| +4% | +$38.2K | 0.01% | 797 |
|
|
2020
Q1 | $1.02M | Buy |
5,558
+253
| +5% | +$45K | 0.02% | 751 |
|
|
2019
Q4 | $885K | Sell |
5,305
-415
| -7% | -$61.7K | 0.01% | 980 |
|
|
2019
Q3 | $749K | Buy |
+5,720
| New | +$745K | 0.01% | 1048 |
|
|
2019
Q1 | – | Sell |
-9,723
| Closed | -$1.14M | – | 1671 |
|
|
2018
Q4 | $1.14M | Buy |
9,723
+175
| +2% | +$20.6K | 0.02% | 622 |
|
|
2018
Q3 | $1.19M | Buy |
9,548
+190
| +2% | +$21K | 0.02% | 672 |
|
|
2018
Q2 | $799K | Buy |
9,358
+140
| +2% | +$10.3K | 0.01% | 804 |
|
|
2018
Q1 | $556K | Buy |
9,218
+3,540
| +62% | +$202K | 0.01% | 899 |
|
|
2017
Q4 | $299K | Buy |
5,678
+40
| +0.7% | +$2.11K | 0.01% | 1044 |
|
|
2017
Q3 | $315K | Buy |
5,638
+110
| +2% | +$5.82K | 0.02% | 838 |
|
|
2017
Q2 | $347K | Buy |
5,528
+2,448
| +79% | +$143K | 0.02% | 563 |
|
|
2017
Q1 | $157K | Buy |
3,080
+70
| +2% | +$3.34K | 0.01% | 774 |
|
|
2016
Q4 | $128K | Buy |
+3,010
| New | +$128K | 0.01% | 568 |
|
Other funds holding AMED
IA
MCI
HNB
State of Alaska Department of Revenue's AMED Position: Q3 2025 in Review
State of Alaska Department of Revenue sold out of Amedisys (AMED) in Q3 2025, closing a stake of 20,687 shares — an estimated $2.03M sold.
State of Alaska Department of Revenue first reported a position in AMED in Q4 2016 and held it in 33 quarters. The position peaked at $2.03M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- State of Alaska Department of Revenue reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- State of Alaska Department of Revenue sold 20,687 Amedisys shares in Q3 2025, an estimated $2.03M.
- State of Alaska Department of Revenue first reported a position in Amedisys in Q4 2016 and held it in 33 quarters.
- State of Alaska Department of Revenue's Amedisys position peaked at $2.03M in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on State of Alaska Department of Revenue's 13F filing for Q3 2025, filed 24 Oct 2025.